Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2008-7-16
pubmed:abstractText
Excess iron has been implicated in cancer risk through increased iron-catalyzed free radical-mediated oxidative stress.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1460-2105
pubmed:author
pubmed:issnType
Electronic
pubmed:day
16
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
996-1002
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18612130-Aged, pubmed-meshheading:18612130-Biological Markers, pubmed-meshheading:18612130-Female, pubmed-meshheading:18612130-Ferritins, pubmed-meshheading:18612130-Follow-Up Studies, pubmed-meshheading:18612130-Humans, pubmed-meshheading:18612130-Incidence, pubmed-meshheading:18612130-Kaplan-Meier Estimate, pubmed-meshheading:18612130-Linear Models, pubmed-meshheading:18612130-Male, pubmed-meshheading:18612130-Middle Aged, pubmed-meshheading:18612130-Neoplasms, pubmed-meshheading:18612130-Odds Ratio, pubmed-meshheading:18612130-Peripheral Vascular Diseases, pubmed-meshheading:18612130-Phlebotomy, pubmed-meshheading:18612130-Proportional Hazards Models, pubmed-meshheading:18612130-Prospective Studies, pubmed-meshheading:18612130-Research Design, pubmed-meshheading:18612130-Risk Assessment, pubmed-meshheading:18612130-Risk Factors, pubmed-meshheading:18612130-Single-Blind Method, pubmed-meshheading:18612130-United States
pubmed:year
2008
pubmed:articleTitle
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.
pubmed:affiliation
Research Service (151), White River Junction VA Medical Center, Department of Veterans Affairs Medical Center, 215 North Hartland Road, White River Junction, VT 05009, USA. leo.r.zacharski@dartmouth.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study